BACKGROUND: THA performed in patients with cognitive deficits or neuromuscular diseases has been associated with a high postoperative dislocation rate. The constrained liner reportedly provides stability in patients with recurrent dislocation. However, achieving stability could be offset by early loosening when used in patients with neurologic diseases. QUESTIONS/PURPOSES: We therefore asked whether constrained liners had a higher risk of loosening when used in primary THA for patients with neurologic diseases. METHODS: We retrospectively reviewed a 144 patients (164 hips) with neuromuscular disease who had a constrained polyethylene insert from 1999 to 2004 and compared them to another 120 patients (132 hips) with neuromuscular disease operated on immediately before this period (from 1994 to 1998) who had a conventional polyethylene insert. RESULTS: Thirty-three (25%) of the 132 hips without a constrained liner were known to have had at least one dislocation and 21 had revision for recurrent dislocation. Ten other hips had revision for loosening of the cup. The survival rate was 82% at 5 years and 77% at 10 years with revision due to recurrent dislocation or loosening of the cup as the endpoint. With a constrained liner, at minimum 5-year followup (mean, 7 years; range, 5-10 years), the incidence of complications, particularly dislocation, was decreased (three dislocations among 164 hips; 2%), with one revision for recurrent dislocation and one revision for loosening. CONCLUSIONS: This constrained acetabular component provides durable protection against dislocation without substantial increased loosening at midterm followup.
BACKGROUND: THA performed in patients with cognitive deficits or neuromuscular diseases has been associated with a high postoperative dislocation rate. The constrained liner reportedly provides stability in patients with recurrent dislocation. However, achieving stability could be offset by early loosening when used in patients with neurologic diseases. QUESTIONS/PURPOSES: We therefore asked whether constrained liners had a higher risk of loosening when used in primary THA for patients with neurologic diseases. METHODS: We retrospectively reviewed a 144 patients (164 hips) with neuromuscular disease who had a constrained polyethylene insert from 1999 to 2004 and compared them to another 120 patients (132 hips) with neuromuscular disease operated on immediately before this period (from 1994 to 1998) who had a conventional polyethylene insert. RESULTS: Thirty-three (25%) of the 132 hips without a constrained liner were known to have had at least one dislocation and 21 had revision for recurrent dislocation. Ten other hips had revision for loosening of the cup. The survival rate was 82% at 5 years and 77% at 10 years with revision due to recurrent dislocation or loosening of the cup as the endpoint. With a constrained liner, at minimum 5-year followup (mean, 7 years; range, 5-10 years), the incidence of complications, particularly dislocation, was decreased (three dislocations among 164 hips; 2%), with one revision for recurrent dislocation and one revision for loosening. CONCLUSIONS: This constrained acetabular component provides durable protection against dislocation without substantial increased loosening at midterm followup.
Authors: Hargovind Dewal; Stephen L Maurer; Peter Tsai; Edward Su; Rudi Hiebert; Paul E Di Cesare Journal: J Arthroplasty Date: 2004-09 Impact factor: 4.757
Authors: Alex Leigh Wojtowicz; Maziar Mohaddes; Daniel Odin; Erik Bülow; Szilard Nemes; Peter Cnudde Journal: Clin Orthop Relat Res Date: 2019-06 Impact factor: 4.176
Authors: Philippe Hernigou; Arnaud Dubory; Damien Potage; François Roubineau; Charles Henri Flouzat Lachaniette Journal: Int Orthop Date: 2016-11-21 Impact factor: 3.075
Authors: Philippe Hernigou; Jean Charles Auregan; Damien Potage; François Roubineau; Charles Henri Flouzat Lachaniette; Arnaud Dubory Journal: Int Orthop Date: 2016-10-20 Impact factor: 3.075
Authors: Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Charles Henri Flouzat Lachaniette Journal: Clin Orthop Relat Res Date: 2016-10 Impact factor: 4.176
Authors: Philippe Hernigou; Louis Ratte; François Roubineau; Jacques Pariat; Guillaume Mirouse; Isaac Guissou; Jerome Allain; Charles Henri Flouzat Lachaniette Journal: Int Orthop Date: 2013-05-12 Impact factor: 3.075